Clinics in Dermatology
Volume 27, Issue 3 , Pages 281-284 , May 2009

Infective dermatitis

References 

  1. Tobinai K. Adult T-cell leukemia-lymphoma. In:  Abeloff M editors. Clinical oncology. 2nd ed.. Oxford, UK: Churchill-Livingstone; 2000;p. 2748–2768
  2. Poiesz BJ, Ruscetti FW, Gazder AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415–7419
  3. Reitz MS, Poiesz BJ, Rucsetti FW, Gallo RC. Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes. Proc Natl Acad Sci U S A. 1981;78:1887–1891
  4. Rho H, Poiesz B, Ruscetti F, Gallo RC. Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human T-cell lymphoma cell line. Virology. 1981;112:355–360
  5. Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Rev Invest Clin. 2004;56:126–129
  6. Hino S, Doi H. Mechanisms of HTLV-I transmission. In:  Romàn GC,  Vernant JC,  Osame M editor. HTLV-I and the nervous system. New York: Alan R. Liss; 1989;p. 495–501
  7. Tsuji Y, Doi H, Yamabe T, Ishimaru T, Miyamoto T, Hino S. Prevention of mother-to-child transmission of human T-lymphotropic virus type-l. Pediatrics. 1990;86:11–17
  8. Richardson JH, Edwards AJ, Cruikshank JK, Rudge P, Dalgleish AG. In vivo tropism of human T-cell leukaemia virus type I. J Virol. 1990;64:5682–5687
  9. Höllsberg P, Wucherpfennig KW, Ausubel LJ, Calvo V, Bierer BE, Hafler DA. Characterization of HTLV-I in vivo infected T cell clones: IL-2 independent growth of nontransformed T cells. J Immunol. 1992;148:3256–3263
  10. Marsh B. Infectious complications of human T-cell leukemia/lymphoma virus type l infection. Clin Infect Dis. 1996;23:138–145
  11. Murphy EL, Hanchard B, Figueroa JP, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43:250–253
  12. Araújo Ade Q, Alfonso CR, Schor D, Leite AC, de Andrada-Serpa MJ. Clinical and demographic features of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil. Acta Neurol Scand. 1993;88:59–62
  13. Levy J, Mascart-Lemone F, Song M, Dobeg M. Immunosuppression by HTLV-I infection. Lancet. 1991;337:308–309
  14. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotrophic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407–410
  15. Bunn PA, Schechter GP, Jaffe E, et al. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med. 1983;309:257–264
  16. Dosaka N, Tanaka T, Miyachi Y, Imamura S, Kakizuka A. Examination of HTLV-I integration in the skin lesions of various types of adult T-cell leukemia (ATL): independence of cutaneous-type ATL confirmed by Southern blot analysis. J Invest Dermatol. 1991;96:196–200
  17. Bunker CB, Whittaker S, Luzzatto L, et al. Indolent cutaneous prodrome of fatal HTLV-I infection. Lancet. 1990;335:426
  18. Kawano F, Yamaguchi K, Nishimura H, Tsuda H, Takatsuki K. Variation in the clinical courses of adult T-cell leukemia. Cancer. 1985;55:851–856
  19. Tschachler E, Hanchard B, Reitz MS. Human retroviral disease: human T-lymphotropic viruses. In:  Fitzpatrick T editors. 4th ed.. Dermatology in general medicine. vol. 2:New York: McGraw-Hill, Inc; 1993;p. 2628–2637
  20. Freedman AS, Nadler LM. Malignant lymphomas. In:  Isselbacher KJ,  Braunwald E,  Wilson JD,  Martin JB,  Fauci AS,  Kasper DL editor. 13th ed.. Harrison's principles of internal medicine. vol. 2:New York: McGraw-Hill Inc; 1994;p. 1774–1788
  21. Matsunaga E, Fujii Y, Shiraishi N, et al. Two cases of adult T-cell leukemia. Br J Dermatol. 1986;114:505–511
  22. Maeda M, Takahashi M. Characterization of skin infiltrating cells in adult T-cell leukemia/lymphoma (ATLL): clinical, histological and immunohistochemical studies on eight cases. Br J Dermatol. 1989;121:603–612
  23. Hashiguchi T, Osame M, Arimura K. Skin manifestations in HTLV-I associated myelopathy (HAM): xerosis and erythema. In:  Romàn GC,  Vernant JC,  Osame M editor. HTLV-I and the nervous system. New York: Alan R. Liss; 1989;p. 443–448
  24. Lenzi ME, Cuzzi-Maya T, Oliveira AL, Andrada-Serpa MJ, Araújo AQ. Dermatological findings of human T lymphotropic vírus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis. Clin Infec Dis. 2003;36:507–513
  25. Mollison LC, Lo ST, Marning G. HTLV-I and scabies in Australian aborigines. Lancet. 1993;341:1281–1282
  26. Rueda R, Blank A. HTLV-I associated cutaneous manifestations. In:  Zaninovic VM editors. HTLV-I truths and questions. Cali, Colombia: Feriva Editores; 1996;p. 212–222
  27. Araújo AQ, Andrada-Serpa MJ, Paulo-Filho TA, Rodrigues MT, Prado LA. Folliculitis decalvans and human T cell lymphotrophic virus I-associated myelopathy/tropical spastic paraparesis. Clin Infec Dis. 1995;20:696–699
  28. Sweet RD. A pattern of eczema in Jamaica. Br J Dermatolol. 1966;78:93–100
  29. Walshe MM. Infective dermatitis in Jamaican children. Br J Dermatol. 1967;79:229–236
  30. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker of HTLV-I infection. Lancet. 1990;336:1345–1347
  31. Hanchard B, LaGrenade L, Carberry C, et al. Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years. Lancet. 1991;338:1593–1594
  32. LaGrenade L, Manns A, Fletcher V, et al. Clinical, pathological and immunologic features of human T-lymphotrophic virus type 1-associated infective dermatitis in children. Arch Dermatol. 1998;134:439

PII: S0738-081X(08)00219-8

doi: 10.1016/j.clindermatol.2008.10.007

Clinics in Dermatology
Volume 27, Issue 3 , Pages 281-284 , May 2009

Article Tools

* Image Usage & Resolution